Search results for "HOS"

showing 10 items of 15105 documents

CCDC 766061: Experimental Crystal Structure Determination

2011

Related Article: F.Pelletier, V.Comte, A.Massard, M.Wenzel, S.Toulot, P.Richard, M.Picquet, P.Le Gendre, O.Zava, F.Edafe, A.Casini, P.J.Dyson|2010|J.Med.Chem.|53|6923|doi:10.1021/jm1004804

(mu~2~-Chloro)-(mu~2~-eta^5^-diphenylphosphino-cyclopentadienyl)-dichloro-(eta^5^-cyclopentadienyl)-(eta^6^-p-cymene)-ruthenium-titanium tetraphenylborateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates

researchProduct

CCDC 256921: Experimental Crystal Structure Determination

2005

Related Article: L.Bareille, P.Le Gendre, P.Richard, C.Moise|2005|Eur.J.Inorg.Chem.||2451|doi:10.1002/ejic.200401028

(mu~2~-eta^5^-(2-(Diphenylphosphino)ethyl)cyclopentadienyl-P)-bis(benzoato-O)-dichloro-(eta^5^-cyclopentadienyl)-(eta^6^-p-cymene)-ruthenium-titanium benzoic acid dichloromethane solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates

researchProduct

CCDC 225461: Experimental Crystal Structure Determination

2004

Related Article: M.G.Basallote, F.Estevan, M.Feliz, M.J.Fernandez-Trujillo, D.A.Hoyos, R.Llusar, S.Uriel, C.Vicent|2004|Dalton Trans.||530|doi:10.1039/b315841a

(mu~3~-Selenido)-tris(mu~2~-selenido)-dihydrido-hydroxy-tris(12-bis(dimethylphosphino)ethane-PP')-tri-tungsten tetraphenylborateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates

researchProduct

CCDC 883708: Experimental Crystal Structure Determination

2013

Related Article: Julia R. Shakirova, Elena V. Grachova, Alexei S. Melnikov, Vladislav V. Gurzhiy, Sergey P. Tunik, Matti Haukka, Tapani A. Pakkanen, and Igor O. Koshevoy|2013|Organometallics|32|4061|doi:10.1021/om301100v

(mu~3~-tris(Diphenylphosphino)methane)-bis(mu~2~-eta^2^-3-hydroxy-33-diphenylprop-1-yn-1-yl)-bromo-(3-hydroxy-33-diphenylprop-1-yn-1-yl)-copper-tri-gold acetone solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates

researchProduct

CCDC 955946: Experimental Crystal Structure Determination

2013

(mu~3~-tris(Diphenylphosphino)methane)-bis(mu~2~-eta^2^-3-hydroxy-33-diphenylprop-1-yn-1-yl)-chloro-(3-hydroxy-33-diphenylprop-1-yn-1-yl)-copper-tri-gold acetone solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates

researchProduct

CCDC 955945: Experimental Crystal Structure Determination

2013

(mu~3~-tris(Diphenylphosphino)methane)-tris(mu~2~-eta^2^-cyclohexylethynyl)-copper-tri-gold hexafluorophosphate dichloromethane solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates

researchProduct

CCDC 998787: Experimental Crystal Structure Determination

2014

Related Article: Roman I. Zubatyuk, Anna A. Sinelshchikova, Yulia Y. Enakieva, Yulia G. Gorbunova, Aslan Y. Tsivadze, Sergey E. Nefedov, Alla Bessmertnykh-Lemeune, Roger Guilard, Oleg V. Shishkin|2014|CrystEngComm|16|10428|doi:10.1039/C4CE01623H

(tetraethyl (1020-diphenylporphyrin-515-diyl)bis(phosphonatato))-platinum(ii)Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates

researchProduct

CCDC 1825951: Experimental Crystal Structure Determination

2018

Related Article: Jacques Pliquett, Souheila Amor, Miguel Ponce-Vargas, Myriam Laly, Cindy Racoeur, Yoann Rousselin, Franck Denat, Ali Bettaïeb, Paul Fleurat-Lessard, Catherine Paul, Christine Goze, Ewen Bodio|2018|Dalton Trans.|47|11203|doi:10.1039/C8DT02364F

({2-[(5-chloro-1H-pyrrol-2-yl)(phenyl)methylidene]-N-[2-(diphenylphosphanyl)ethyl]-2H-pyrrol-5-aminato}(difluoro)boron)-chloro-gold(i) dichloromethane solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates

researchProduct

Structure, morphology and photoluminescence emissions of ZnMoO4: RE 3+=Tb3+ - Tm3+ - X Eu3+ (x = 1, 1.5, 2, 2.5 and 3 mol%) particles obtained by the…

2018

Made available in DSpace on 2018-12-11T17:36:34Z (GMT). No. of bitstreams: 0 Previous issue date: 2018-06-25 Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Ministerio de Economía y Competitividad ZnMoO4 and ZnMoO4: RE3+ = 1% Tb3+, 1% Tm3+, x Eu3+ (x = 1, 1.5, 2, 2.5 and 3 mol%) particles were prepared by a sonochemical method. The influence of the dopant content on photoluminescent behavior was investigated. The X-ray diffraction results confirmed the formation of the α-ZnMoO4 phase with a triclinic crystalline structure. The influence of th…

- Tm3+- Eu3+PhotoluminescenceMaterials scienceEu3+Tm3+Band gapAnalytical chemistryPhosphor02 engineering and technologyTriclinic crystal system010402 general chemistry01 natural sciencesSonochemical method PhotoluminescenceTb3+Materials ChemistrySINTERIZAÇÃOPhotoluminescenceQuenchingDopantMechanical EngineeringMetals and AlloysTb3+ [ZnMoO4]021001 nanoscience & nanotechnology0104 chemical sciencesMechanics of MaterialsDensity functional theoryZnMoO4Wulff constructionSonochemical method0210 nano-technology

researchProduct

Prevalence and characteristics of antidepressant drug prescriptions in older Italian patients.

2012

ABSTRACTBackground: During last few decades, the proportion of elderly persons prescribed with antidepressants for the treatment of depression and anxiety has increased. The aim of this study was to evaluate prevalence of antidepressant prescription and related factors in elderly in-patients, as well as the consistency between prescription of antidepressants and specific diagnoses requiring these medications.Methods: Thirty-four internal medicine and four geriatric wards in Italy participated in the Registro Politerapie SIMI–REPOSI study during 2008. In all, 1,155 in-patients, 65 years or older, were enrolled. Prevalence of the use of antidepressants was calculated at both admission and dis…

---DrugMalemedicine.medical_specialtyMultivariate analysisSettore MED/09 - Medicina Internaantidepressants; prescription; elderly; hospitalization; dementiamedia_common.quotation_subjectLogistic regressionelderlySex FactorsInternal medicinemedicinePrevalenceantidepressant drugsDementiaHumansMedical prescriptionPractice Patterns Physicians'PsychiatryDepression (differential diagnoses)media_commonAgedprescriptionantidepressantbusiness.industryDepressionAge Factorsmedicine.diseaseSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheAntidepressive AgentsPsychiatry and Mental healthClinical PsychologyLogistic Models---; elderly; antidepressant drugs; PrevalenceItalyAnxietyAntidepressantDementiaFemaleGeriatrics and Gerontologymedicine.symptombusinessGerontologyhospitalizationInternational psychogeriatrics

researchProduct